PhyMed, backed by OTPP, awaits final bids

The Credit Suisse-run process, targeting strategic buyers, comes six-plus years after the Canadian pension fund's LBO of the anesthesia platform.

To read this article, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to read this article and more for free.

Share this